We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 18.77%
This Fund
S&P 500
This Quarter Est. Return
-5.21%
1 Year Est. Return
+18.77%
3 Year Est. Return
+63.89%
5 Year Est. Return
+85.69%
10 Year Est. Return
+323.28%
AUM
$198M
AUM Growth
-$10.9M
Cap. Flow
+$1.65M
Cap. Flow %
0.83%
Top 10 Hldgs %
33.56%
Holding
111
New
2
Increased
20
Reduced
48
Closed
5

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.66M
2
GSK icon
GSK
GSK
+$2.77M
3
HLN icon
Haleon
HLN
+$591K
4
QCOM icon
Qualcomm
QCOM
+$429K
5
META icon
Meta Platforms (Facebook)
META
+$45.2K

Top Sells

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$3.8M
2
UNH icon
UnitedHealth
UNH
+$422K
3
LUV icon
Southwest Airlines
LUV
+$226K
4
HDV
iShares Core High Dividend ETF
HDV
+$210K
5
V icon
Visa
V
+$210K

Sector Composition

Rank Sector Weight
1 Healthcare 32.17%
2 Technology 29.08%
3 Industrials 10.93%
4 Financials 7.92%
5 Communication Services 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$13.7M 6.93%
99,155
-338
-0.3% -$53K
MSFT icon
2
Microsoft
MSFT
$2.89T
$8.19M 4.15%
35,183
+2
+0% +$528
REGN icon
3
Regeneron Pharmaceuticals
REGN
$69.9B
$7.62M 3.86%
11,064
-50
-0.4% -$31.5K
VRTX icon
4
Vertex Pharmaceuticals
VRTX
$122B
$6.68M 3.38%
23,080
-65
-0.3% -$18.7K
QCOM icon
5
Qualcomm
QCOM
$179B
$6.36M 3.22%
56,299
+3,121
+6% +$429K
INFY icon
6
Infosys
INFY
$47.4B
$5.56M 2.81%
327,776
– –
TROW icon
7
T. Rowe Price
TROW
$25.5B
$4.72M 2.39%
44,964
+37
+0.1% +$4.41K
META icon
8
Meta Platforms (Facebook)
META
$1.51T
$4.53M 2.29%
33,395
+279
+0.8% +$45.2K
GILD icon
9
Gilead Sciences
GILD
$162B
$4.53M 2.29%
73,433
-576
-0.8% -$36.3K
CHRW icon
10
C.H. Robinson
CHRW
$20.6B
$4.42M 2.24%
45,876
-371
-0.8% -$39.9K
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$3.99T
$4.2M 2.12%
43,860
+33,000
+304% +$3.66M
NTAP icon
12
NetApp
NTAP
$33.3B
$4.06M 2.06%
65,669
+12
+0% +$834
INCY icon
13
Incyte
INCY
$23.7B
$3.81M 1.93%
57,182
+500
+0.9% +$36.9K
EXPD icon
14
Expeditors International
EXPD
$22.4B
$3.76M 1.9%
42,530
-50
-0.1% -$5K
BMY icon
15
Bristol-Myers Squibb
BMY
$128B
$3.72M 1.88%
52,296
+27
+0.1% +$1.96K
PYPL icon
16
PayPal
PYPL
$49.5B
$3.54M 1.79%
41,169
+450
+1% +$39.9K
AZN icon
17
AstraZeneca
AZN
$263B
$3.44M 1.74%
31,326
-129
-0.4% -$16.4K
AMGN icon
18
Amgen
AMGN
$203B
$3.35M 1.7%
14,864
-24
-0.2% -$5.82K
UNH icon
19
UnitedHealth
UNH
$379B
$3.21M 1.62%
6,356
-802
-11% -$422K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.07T
$3.15M 1.6%
11,813
-50
-0.4% -$14.2K
CTAS icon
21
Cintas
CTAS
$84.4B
$3.13M 1.58%
32,248
– –
CSCO icon
22
Cisco
CSCO
$452B
$3.03M 1.53%
75,767
-218
-0.3% -$9.67K
CI icon
23
Cigna
CI
$77B
$3.01M 1.52%
10,834
-100
-0.9% -$28.1K
CHKP icon
24
Check Point Software Technologies
CHKP
$13.6B
$2.84M 1.44%
25,314
-50
-0.2% -$6.05K
MRK icon
25
Merck
MRK
$323B
$2.55M 1.29%
29,600
-99
-0.3% -$8.84K
1
2 3 4 5

Similar funds

FAL
Focused Alpha LLC Denver, Colorado $324M AUM
QPW
Quantum Private Wealth Tampa, Florida $324M AUM 37.9% 1-Year Est. Return
BOS
Bank of Stockton Stockton, California $323M AUM 22.34% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
WAOI
Wealth Advisors of Iowa West Des Moines, Iowa $323M AUM 14.23% 1-Year Est. Return
CRI
Commonwealth Retirement Investments Richmond, Virginia $323M AUM 24.17% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

AIMZ Investment Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, AIMZ Investment Advisors held 111 positions worth $198M, down 5.2% from $209M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

AIMZ Investment Advisors's Q3 2022 filing shows 2 new, 20 increased, 48 reduced and 5 closed positions. Its largest new stake was GSK: 73,064 shares worth $2.15M. The largest sale was CDK Global, Inc., an estimated $3.8M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

  • AIMZ Investment Advisors's largest Q3 2022 buy was GSK: 73,064 shares worth $2.15M.
  • AIMZ Investment Advisors added most to Alphabet (Google) Class A in Q3 2022, an estimated $3.66M increase.
  • AIMZ Investment Advisors's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $422K.
  • AIMZ Investment Advisors fully exited CDK Global, Inc. in Q3 2022, selling an estimated $3.8M.
  • AIMZ Investment Advisors's ten largest holdings make up 34% of its $198M portfolio in Q3 2022.
  • AIMZ Investment Advisors opened 2 new positions and closed 5 in Q3 2022.
  • AIMZ Investment Advisors's portfolio value fell 5.2% quarter-over-quarter to $198M.

Based on AIMZ Investment Advisors's 13F filing for Q3 2022, filed 15 Nov 2022.